Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.07 USD | -2.88% | +7.62% | +24.13% |
05-17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.13% | 191M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-2.71% | 21.58B | |
-6.03% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc., Parent Project Muscular Dystrophy - Special Call